Marshall Wace
OLMA icon

Marshall Wace’s Olema Pharmaceuticals OLMA Stock Holding History

Marshall Wace’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-360,394
Closed -$9.01M – 3550
2025
Q4 		$9.01M Buy
+360,394
New +$6.41M 0.01% 921
2025
Q3 		– Sell
-12,800
Closed -$54.5K – 3262
2025
Q2 		$54.5K Sell
12,800
-307,150
-96% -$1.37M ﹤0.01% 2594
2025
Q1 		$1.2M Buy
319,950
+127,007
+66% +$639K ﹤0.01% 1706
2024
Q4 		$1.12M Sell
192,943
-47,444
-20% -$474K ﹤0.01% 1678
2024
Q3 		$2.87M Sell
240,387
-348,609
-59% -$4.46M ﹤0.01% 1231
2024
Q2 		$6.37M Buy
588,996
+41,193
+8% +$447K 0.01% 906
2024
Q1 		$6.2M Buy
547,803
+257,082
+88% +$3.32M 0.01% 909
2023
Q4 		$4.08M Buy
290,721
+203,987
+235% +$2.74M 0.01% 980
2023
Q3 		$1.07M Buy
+86,734
New +$884K ﹤0.01% 1476
2023
Q2 		– Sell
-35,700
Closed -$124K – 2825
2023
Q1 		$124K Sell
35,700
-90,949
-72% -$371K ﹤0.01% 2478
2022
Q4 		$310K Sell
126,649
-20,185
-14% -$58.9K ﹤0.01% 2556
2022
Q3 		$404K Buy
146,834
+9,368
+7% +$39.7K ﹤0.01% 2819
2022
Q2 		$558K Buy
+137,466
New +$436K ﹤0.01% 2741
2022
Q1 		– Sell
-77,092
Closed -$721K – 3827
2021
Q4 		$721K Buy
77,092
+31,514
+69% +$653K ﹤0.01% 2628
2021
Q3 		$1.26M Buy
+45,578
New +$1.23M 0.01% 1870

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Marshall Wace's OLMA Position: Q1 2026 in Review

Marshall Wace sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 360,394 shares — an estimated $9.01M sold.

Marshall Wace first reported a position in OLMA in Q3 2021 and held it in 15 quarters. The position peaked at $9.01M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Marshall Wace reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 360,394 Olema Pharmaceuticals shares in Q1 2026, an estimated $9.01M.
  • Marshall Wace first reported a position in Olema Pharmaceuticals in Q3 2021 and held it in 15 quarters.
  • Marshall Wace's Olema Pharmaceuticals position peaked at $9.01M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.